Shadi Tabibian: Molecular Diagnosis of Inherited Platelet Disorders
Shadi Tabibian, Director of the Iranian Comprehensive Hemophilia Care Center (ICHC) and Deputy of research at Blood Diseases Research Centers, Iran University of Medical Sciences, shared a post on LinkedIn:
“Proud to share our newly published narrative review in Thrombosis Journal (2025):
Title: Molecular diagnosis of inherited platelet disorders: a tale of two realities – advanced vs. resource-limited setting
Authors: Seyed Mehrab Safdari, Sina Jozdani, Mahsa Mottaghizadeh-Jazi, Maryam Shayanmanesh, Alireza Khanahmad, Mehdi Bakhtiyaridovvombaygi, Azadeh Rezazadeh and Shadi Tabibian
In this review, we discuss how molecular technologies—particularly next-generation sequencing (NGS)—are transforming the diagnosis of inherited platelet disorders, while also emphasizing why phenotypic and laboratory investigations (platelet function testing, flow cytometry, immunofluorescence, and electron microscopy) remain essential for first-line evaluation.
We also highlight a critical global challenge: in resource-limited settings, restricted access to genetic platforms (cost, infrastructure, and expertise) can delay or prevent accurate diagnosis—ultimately affecting patient care.
Key takeaways:
• NGS improves diagnostic precision and supports tailored management
• Conventional laboratory pathways remain foundational for initial diagnosis
• Closing the diagnostic gap requires affordable testing models, collaboration, and capacity building
I’d be honored if you read the paper and share your thoughts or experience from your own setting.”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis